In this review, we overview the main features and functions of NK cells, focusing on their role in cell-mediated immune response to tumor cells. In parallel, we discuss the information available in the field of NK cell receptors and offer a wide general overview of functional aspects of cell targeting and killing, focusing on the recent acknowledgments on the efficacy of NK cells after cytokine and mAb administration in cancer therapy. Since efficacy of NK cell-based immunotherapy has been proven in KIR-mismatch regimens or in TRAIL-dependent apoptosis, the ability to manipulate the balance of activating and inhibitory receptors on NK cells and of their cognate ligands, as well as the sensitivity of tumor cells to apoptosis, opens new perspectives for NK cell-based immunotherapy. Copyright © 2007 by The American Association of Immunologists, Inc.

NK cells and cancer / Zamai, L; Ponti, Cristina; Mirandola, Prisco; Gobbi, Giuliana; Papa, Stefania; Galeotti, Lorena; Cocco, LUCIO ILDEBRANDO; Vitale, Marco. - In: THE JOURNAL OF IMMUNOLOGY. - ISSN 1550-6606. - 178:7(2007), pp. 4011-4016. [10.4049/​jimmunol.178.7.4011]

NK cells and cancer

PONTI, CRISTINA;MIRANDOLA, Prisco;GOBBI, Giuliana;PAPA, STEFANIA;GALEOTTI, LORENA;COCCO, LUCIO ILDEBRANDO;VITALE, Marco
2007

Abstract

In this review, we overview the main features and functions of NK cells, focusing on their role in cell-mediated immune response to tumor cells. In parallel, we discuss the information available in the field of NK cell receptors and offer a wide general overview of functional aspects of cell targeting and killing, focusing on the recent acknowledgments on the efficacy of NK cells after cytokine and mAb administration in cancer therapy. Since efficacy of NK cell-based immunotherapy has been proven in KIR-mismatch regimens or in TRAIL-dependent apoptosis, the ability to manipulate the balance of activating and inhibitory receptors on NK cells and of their cognate ligands, as well as the sensitivity of tumor cells to apoptosis, opens new perspectives for NK cell-based immunotherapy. Copyright © 2007 by The American Association of Immunologists, Inc.
NK cells and cancer / Zamai, L; Ponti, Cristina; Mirandola, Prisco; Gobbi, Giuliana; Papa, Stefania; Galeotti, Lorena; Cocco, LUCIO ILDEBRANDO; Vitale, Marco. - In: THE JOURNAL OF IMMUNOLOGY. - ISSN 1550-6606. - 178:7(2007), pp. 4011-4016. [10.4049/​jimmunol.178.7.4011]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2812433
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 213
  • ???jsp.display-item.citation.isi??? 189
social impact